KPVCellular PeptideSafety Rating 7/10
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Price Comparison
Compare vendors · per 10mg
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| Puratek PeptidesBest $/mgCOA ✓ · 3POut of stock | $31.46 | $3.15 | May 19, 2026 | Buy → |
| Amino ClubCOA ✓ · 3P | $31.99 | $3.20 | May 14, 2026 | Buy → |
| Guru PeptidesCOA unknown | $39.99 | $4.00 | May 16, 2026 | Buy → |
| Olympex SolutionsCOA ✓ · 3P | $39.99 | $4.00 | Apr 6, 2026 | Buy → |
| Ascension PeptidesCOA ✓ · 3P | $39.99 | $4.00 | Apr 16, 2026 | Buy → |
Overview
About KPV
Mechanism of action
C-terminal tripeptide of alpha-MSH; binds melanocortin receptors (MC1R, MC3R); potent anti-inflammatory; inhibits NF-κB; reduces pro-inflammatory cytokines (TNF-α, IL-6).
Safety profile
Very well-tolerated. Minimal known side effects. Injection site reactions possible. · Alpha-MSH fragment; endogenous origin; anti-inflammatory in studies; no adverse signals identified
Storage
Stability & handling
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops KPV below your target.
Safety & Interactions
Contraindications & Drug Interactions
Research use only — not medical advice. Consult a licensed physician before using any peptide. Sources are cited where available.
Alpha-MSH fragment; no adverse signals in limited research data.
Related pages
More on KPV
Stack & Compare
Frequently Researched Together
Research
Studies & key findings
- C-terminal tripeptide of α-MSH (Lys-Pro-Val) that retains anti-inflammatory potency while lacking melanogenic activity, acting via the MC1 receptor.
- PepT1 transporter in the intestinal epithelium actively takes up KPV, enabling oral and local delivery directly to inflamed GI tissue.